期刊文献+

高效液相色谱法测定人血浆中拉莫三嗪浓度 被引量:2

Determination of the Concentration of Lamotrigine in Human Plasma by HPLC
下载PDF
导出
摘要 目的建立高效液相色谱法测定人血浆中拉莫三嗪的浓度。方法以Diamonsil TM C18反相柱(150mm×4.6mm,5μm)为色谱柱,流动相为0.03mol·L^-1醋酸铵-甲醇(58∶42);流速:1.0m L·min^-1;柱温:30℃;检测波长:310nm。以乙酸乙酯为提取剂。结果拉莫三嗪浓度在0.5~24.0μg·m L^-1范围内,峰面积与浓度线性关系良好;拉莫三嗪的低、中、高浓度(1.0,8.0,20.0μg·m L^-1)相对平均回收率大于95%;提取回收率大于75%。日内、日间RSD均低于10%(n=5)。分析方法的检测限0.1μg·m L^-1;拉莫三嗪曲线回归方程为:Y=0.0899X+0.0215,r=0.9989(n=7);结论该方法灵敏、准确、简单、快速,能够满足体内药物分析的要求。 OBJECTIVE To establish a method for determining the concentration of lamotrigine in human plasma by HPLC. METHODS The drug from plasma was analyzed in a reverse phase HPLC system C18column(150 mm × 4. 6mm,5μm); mobile phase consisted of 0. 03mol·L^-1ammonium acetate-methanol(58 ∶ 42); the flow rate was1. 0m L · min^-1; the detection wavelength was at 310 nm. Ethyl acetate was used as extracting solvent. RESULTS The peak area and concentration of Lamotrigine in 0. 5 ~ 24. 0μg·m L^-1has good linearity. The average recoveries of lamotrigne in low,middle and high concentrations(1. 0,8. 0,20. 0μg·m L^-1) were over 95%respectively; the extraction recovery over 75%. The intra-day and inter-day variation(RSD) was less than 10%(n =5). The minimum detectable concentration of lamotrigne was 0. 1μg · m L^-1. The regression equation was Y =0. 0899 X + 0. 0215. r = 0. 9989(n = 7). CONCLUSION The method is sensitive,accurate,simple,fast. It is suitable for deter mination of drug analysis.
出处 《海峡药学》 2014年第11期246-248,共3页 Strait Pharmaceutical Journal
关键词 高效液相色谱法 拉莫三嗪 血药浓度 HPLC Lamotrigine Plasma concentration
  • 相关文献

参考文献10

  • 1Sharma C,Dubey R,Kumarh,et al.Food reduces the bioavailability of lamotrigine[J].Indian J Med Res,2005,121(5):659-664.
  • 2杜军,李忆军.RP-HPLC测定拉莫三嗪和苯巴比妥的血药浓度[J].中国医药导报,2010,7(8):39-41. 被引量:6
  • 3宋志彬,廖卫平,杨少青,蒲蜀湘,易咏红,赵绮华.拉莫三嗪临床药物代谢动力学及其药物相互作用研究[J].中华神经科杂志,2005,38(8):517-519. 被引量:12
  • 4Stefan H,Feuerstein T J.Novel anticonvulsant drugs[J].Pharmacol Ther,2007,113(1):165-183.
  • 5Newport D J,Pennell P B,CALAMARAS M R,et al.Lamotrigine in breast milk and nursing infants:determination of exposure[J].Pediatrics,2008,122(1):223-231.
  • 6Glaxo sk.Lamictal(lamotrigine)prescribing information[R].Res Triangle Park,N C,USA,2005.
  • 7宋志彬,廖卫平,易咏红,郑宣,扬春霞,赵绮华,蒲蜀湘.拉莫三嗪在有效血药浓度时对脑电波的影响[J].广州医学院学报,2003,31(4):16-18. 被引量:14
  • 8Walker M C,Patsalospn.Clinical phar macokenetics of new antiepilepic drugs[J].J Pharmac 2005,67(3):351-384.
  • 9Donatella L,Paololg.New micromethodf or the deter mination of lamotrigine in hum an plasm a by high perform anceliquid chromatography[J].J Chromatogr B,2007,691:139-144.
  • 10Nadia R B,Antonio FM.Validated high perform anceliquid chromatographic method forthed eterm in ation of lamotrigine in hum an plasma[J].J Chromatogr B,2000,741:289-293.

二级参考文献25

共引文献26

同被引文献15

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部